tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AstraZeneca pauses planned $270M investment in Britain, Reuters reports
PremiumThe FlyAstraZeneca pauses planned $270M investment in Britain, Reuters reports
6d ago
Merck’s capvaxive shows positive immune response in pneumococcal disease
Premium
The Fly
Merck’s capvaxive shows positive immune response in pneumococcal disease
7d ago
Merck’s Strategic Advantage in ADCs for ES-SCLC: A Buy Rating by Daina Graybosch
Premium
Ratings
Merck’s Strategic Advantage in ADCs for ES-SCLC: A Buy Rating by Daina Graybosch
7d ago
Trump signs memorandum mandating pharma ads give more info on risks
PremiumThe FlyTrump signs memorandum mandating pharma ads give more info on risks
8d ago
Merck & Co. Closes $6 Billion Notes Offering
Premium
Company Announcements
Merck & Co. Closes $6 Billion Notes Offering
9d ago
Daiichi, Merck announce results from phase 2 trial of ifinatamab deruxtecan
Premium
The Fly
Daiichi, Merck announce results from phase 2 trial of ifinatamab deruxtecan
11d ago
Merck & Company’s Positive Clinical Trial Results and Strategic Positioning Drive Buy Rating
PremiumRatingsMerck & Company’s Positive Clinical Trial Results and Strategic Positioning Drive Buy Rating
21d ago
Merck doses first patient in HERTHENA-Breast04 trial
Premium
The Fly
Merck doses first patient in HERTHENA-Breast04 trial
22d ago
Market Wrap: U.S. Equities Slump to Start the Week, with the Dow Shedding 349 Points
Premium
Market News
Market Wrap: U.S. Equities Slump to Start the Week, with the Dow Shedding 349 Points
24d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100